[1] [1] SUNG H, FERLAY J, SIEGEL R L,et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA: A Cancer Journal for Clinicians, 2021, 71(3): 209-249.

[3] [3] LAN M H, ZHAO S J, LIU W M,et al. Photosensitizers for photodynamic therapy[J]. Advanced Healthcare Materials, 2019, 8(13): 1900132.

[4] [4] MCFARLAND S A, MANDEL A, DUMOULIN-WHITE R,et al. Metal-based photosensitizers for photodynamic therapy: the future of multimodal oncology?[J]. Current Opinion in Chemical Biology, 2020, 56: 23-27.

[5] [5] CHEN J M, FAN T J, XIE Z J,et al. Advances in nanomaterials for photodynamic therapy applications: status and challenges[J]. Biomaterials, 2020, 237: 119827.

[7] [7] YANG S, LI N J, LIU Z,et al. Amphiphilic copolymer coated upconversion nanoparticles for near-infrared light-triggered dual anticancer treatment[J]. Nanoscale, 2014, 6(24): 14903-14910.

[8] [8] ZHANG C, ZHAO K L, BU W B,et al. Marriage of scintillator and semiconductor for synchronous radiotherapy and deep photodynamic therapy with diminished oxygen dependence[J]. Angewandte Chemie International Edition, 2015, 54(6): 1770-1774.

[9] [9] SNCHEZ-RAMREZ D R, DOMNGUEZ-ROS R, JUREZ J,et al. Biodegradable photoresponsive nanoparticles for chemo-, photothermal- and photodynamic therapy of ovarian cancer[J]. Materials Science and Engineering C, 2020, 116: 111196.

[10] [10] DOUGHERTY T J. Hematoporphyrin as a photosensitizer of tumors[J]. Photochemistry and Photobiology, 1983, 38(3): 377-379.

[12] [12] THOMAS A P, PALANIKUMAR L, JEENA M T,et al. Cancer-mitochondria-targeted photodynamic therapy with supramolecular assembly of HA and a water soluble NIR cyanine dye[J]. Chemical Science, 2017, 8(12): 8351-8356.

[13] [13] SONG Y C, LI Y T, ZHANG Y D,et al. Self-quenching synthesis of coordination polymer pre-drug nanoparticles for selective photodynamic therapy[J]. Journal of Materials Chemistry B, 2019, 7(48): 7776-7782.

[14] [14] DONOHOE C, SENGE M O, ARNAUT L G,et al. Cell death in photodynamic therapy: from oxidative stress to anti-tumor immunity[J]. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2019, 1872(2): 188308.

[18] [18] SMYTH E C, NILSSON M, GRABSCH H I,et al. Gastric cancer[J]. Lancet, 2020, 396(10251): 635-648.

[20] [20] XU T L, XIE F L, XU D Z,et al.MiR-200b suppresses gastric cancer cell migration and invasion by inhibiting NRG1 through ERBB2/ERBB3 signaling[J]. Journal of Oncology, 2021, 2021: 4470778.

[21] [21] TANAKA M, SASAKI M, SUZUKI T,et al.Combination of talaporfin photodynamic therapy and poly (ADP-Ribose) polymerase (PARP) inhibitor in gastric cancer[J]. Biochemical and Biophysical Research Communications, 2021, 539: 1-7.

[22] [22] KORSAK B, ALMEIDA G M, ROCHA S,et al.Porphyrin modified trastuzumab improves efficacy of HER2 targeted photodynamic therapy of gastric cancer[J]. International Journal of Cancer, 2017, 141(7): 1478-1489.

[23] [23] XIN J, WANG S J, WANG J,et al.Nanosystem integrated with photosensitizer and novel targeting chemotherapy agent for gastric cancer chemo-photodynamic combined therapy[J]. Journal of Biomedical Nanotechnology, 2018, 14(8): 1430-1447.

[24] [24] MIMURA S, ITO Y, NAGAYO T,et al. Cooperative clinical trial of photodynamic therapy with photofrin II and excimer dye laser for early gastric cancer[J]. Lasers in Surgery and Medicine, 1996, 19(2): 168-172.

[25] [25] NAKAMURA H, YANAI H, NISHIKAWA J,et al. Experience with photodynamic therapy (endoscopic laser therapy) for the treatment of early gastric cancer[J]. Hepato-Gastroenterology, 2001, 48(42): 1599-1603.

[27] [27] RABENSTEIN T, MAY A, GOSSNER L,et al.Invisible gastric carcinoma detected by random biopsy: long-term results after photodynamic therapy[J]. Endoscopy, 2008, 40(11): 899-904.

[28] [28] VALE F F, OLEASTRO M. Overview of the phytomedicine approaches againstHelicobacter pylori[J]. World Journal of Gastroenterology, 2014, 20(19): 5594-5609.

[29] [29] MLYNARCZYK D T, DLUGASZEWSKA J, FALKOWSKI M,et al.Tribenzoporphyrazines with dendrimeric peripheral substituents and their promising photocytotoxic activity againstStaphylococcus aureus[J]. Journal of Photochemistry and Photobiology B: Biology, 2020, 204: 111803.

[30] [30] WANG Z G, MA R, YAN L,et al. Combined chemotherapy and photodynamic therapy using a nanohybrid based on layered double hydroxides to conquer cisplatin resistance[J]. Chemical Communications, 2015, 51(58): 11587-11590.

[31] [31] HE C B, LIU D M, LIN W B. Self-assembled core-shell nanoparticles for combined chemotherapy and photodynamic therapy of resistant head and neck cancers[J]. ACS Nano, 2015, 9(1): 991-1003.

[32] [32] XU S, BULIN A L, HURBIN A,et al. Photodynamic diagnosis and therapy for peritoneal carcinomatosis: emerging perspectives[J]. Cancers, 2020, 12(9): 2491.

[33] [33] BBASAKOOR F, WOODHAMS J, FAROOQUI N,et al. Safe ablation of the anal mucosa and perianal skin in rats using photodynamic therapy: a promising approach for treating anal intraepithelial neoplasia[J]. Photodiagnosis and Photodynamic Therapy, 2013, 10(4): 566-574.

[34] [34] KUKCINAVICIUTE E, SASNAUSKIENE A, DABKEVICIENE D,et al. Effect of mTHPC-mediated photodynamic therapy on 5-fluorouracil resistant human colorectal cancer cells[J]. Photochemical & Photobiological Sciences, 2017, 16(7): 1063-1070.

[35] [35] HAO Y, MA S, GU Z L,et al. Combination of photodynamic therapy and stimulator of interferon genes (Sting) agonist inhibits colorectal tumor growth and recurrence[J]. Cancer Communications, 2023, 43(4): 513-518.

[37] [37] NKUNE N W, KRUGER C A, ABRAHAMSE H. Possible enhancement of photodynamic therapy (PDT) colorectal cancer treatment when combined with cannabidiol[J]. Anti-Cancer Agents in Medicinal Chemistry, 2021, 21(2): 137-148.

[39] [39] RUMALLA A, BARON T H, WANG K K,et al.Endoscopic application of photodynamic therapy for cholangiocarcinoma[J]. Gastrointestinal Endoscopy, 2001, 53(4): 500-504.

[40] [40] NANASHIMA A, HIYOSHI M, IMAMURA N,et al.Recent advances in photodynamic imaging and therapy in hepatobiliary malignancies: clinical and experimental aspects[J]. Current Oncology, 2021, 28(5): 4067-4079.

[41] [41] GONZALEZ-CARMONA M A, BOLCH M, JANSEN C,et al. Combined photodynamic therapy with systemic chemotherapy for unresectable cholangiocarcinoma[J]. Alimentary Pharmacology & Therapeutics, 2019, 49(4): 437-447.

[42] [42] WAGNER A, DENZER U W, NEUREITER D,et al.Temoporfin improves efficacy of photodynamic therapy in advanced biliary tract carcinoma: a multicenter prospective phase II study[J]. Hepatology, 2015, 62(5): 1456-1465.

[43] [43] BAE B C, YANG S G, JEONG S,et al. Polymeric photosensitizer-embedded self-expanding metal stent for repeatable endoscopic photodynamic therapy of cholangiocarcinoma[J]. Biomaterials, 2014, 35(30): 8487-8495.

[44] [44] CHEN P C, YANG T, SHI P D,et al.Benefits and safety of photodynamic therapy in patients with hilar cholangiocarcinoma: a meta-analysis[J]. Photodiagnosis and Photodynamic Therapy, 2022, 37: 102712.

[45] [45] LI Z Y, JIANG X F, XIAO H,et al. Long-term results of ERCP-or PTCS-directed photodynamic therapy for unresectable hilar cholangiocarcinoma[J]. Surgical Endoscopy, 2021, 35(10): 5655-5664.

[46] [46] CHEON Y K, LEE T Y, LEE S M,et al. Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma[J]. HPB, 2012, 14(3): 185-193.

[47] [47] SHIRYAEV A A, MUSAEV G K, LEVKIN V V,et al.Combined treatment of nonresectable cholangiocarcinoma complicated by obstructive jaundice[J]. Photodiagnosis and Photodynamic Therapy, 2019, 26: 218-223.

[50] [50] BOWN S G, ROGOWSKA A Z, WHITELAW D E,et al. Photodynamic therapy for cancer of the pancreas[J]. Gut, 2002, 50(4): 549-557.

[51] [51] HUGGETT M T, JERMYN M, GILLAMS A,et al.Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer[J]. British Journal of Cancer, 2014, 110(7): 1698-1704.

[52] [52] CHOI J H, OH D, LEE J H,et al. Initial human experience of endoscopic ultrasound-guided photodynamic therapy with a novel photosensitizer and a flexible laser-light catheter[J]. Endoscopy, 2015, 47(11): 1035-1038.

[53] [53] DEWITT J M, SANDRASEGARAN K, O'NEIL B,et al. Phase 1 study of EUS-guided photodynamic therapy for locally advanced pancreatic cancer[J]. Gastrointestinal Endoscopy, 2019, 89(2): 390-398.

[54] [54] HANADA Y R, PEREIRA S P, POGUE B,et al. EUS-guided verteporfin photodynamic therapy for pancreatic cancer[J]. Gastrointestinal Endoscopy, 2021, 94(1): 179-186.

[55] [55] YANG H Y, LIU R F, XU Y X,et al.Photosensitizer nanoparticles boost photodynamic therapy for pancreatic cancer treatment[J]. Nano-Micro Letters, 2021, 13(1): 35.

[56] [56] LI H, WANG P, DENG Y X,et al. Combination of active targeting, enzyme-triggered release and fluorescent dye into gold nanoclusters for endomicroscopy-guided photothermal/photodynamic therapy to pancreatic ductal adenocarcinoma[J]. Biomaterials, 2017, 139: 30-38.

[57] [57] PENNATHUR A, GIBSON M K, JOBE B A,et al. Oesophageal carcinoma[J]. Lancet, 2013, 381(9864): 400-412.

[58] [58] SONG Y M, LI L, OU Y W,et al. Identification of genomic alterations in oesophageal squamous cell cancer[J]. Nature, 2014, 509(7498): 91-95.

[62] [62] WOLFSEN H C, WOODWARD T A, RAIMONDO M. Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma[J]. Mayo Clinic Proceedings, 2002, 77(11): 1176-1181.

[63] [63] GRAY J, FULLARTON G M. Long term efficacy of photodynamic therapy (PDT) as an ablative therapy of high grade dysplasia in Barrett's oesophagus[J]. Photodiagnosis and Photodynamic Therapy, 2013, 10(4): 561-565.

[64] [64] KOHOUTOVA D, HAIDRY R, BANKS M,et al. Esophageal neoplasia arising from subsquamous buried glands after an apparently successful photodynamic therapy or radiofrequency ablation for Barrett's associated neoplasia[J]. Scandinavian Journal of Gastroenterology, 2015, 50(11): 1315-1321.

[65] [65] LITLE V R, LUKETICH J D, CHRISTIE N A,et al. Photodynamic therapy as palliation for esophageal cancer: experience in 215 patients[J]. The Annals of Thoracic Surgery, 2003, 76(5): 1687-1692.

[66] [66] YOON H Y, CHEON Y K, CHOI H J,et al. Role of photodynamic therapy in the palliation of obstructing esophageal cancer[J]. The Korean Journal of Internal Medicine, 2012, 27(3): 278-284.

[69] [69] HAYASHI T, ASAHINA Y, NAKANISHI H,et al.Evaluation of the efficacy and safety of salvage photodynamic therapy by talaporfin sodium for cervical esophageal cancers and lesions larger than 3 cm[J]. Esophagus, 2021, 18(3): 645-654.

[70] [70] DIDAMSON O C, ABRAHAMSE H. Targeted photodynamic diagnosis and therapy for esophageal cancer: potential role of functionalized nanomedicine[J]. Pharmaceutics, 2021, 13(11): 1943.

[71] [71] MOTOORI M, YANO M, TANAKA K,et al. Intraoperative photodynamic diagnosis of lymph node metastasis in esophageal cancer patients using 5-aminolevulinic acid[J]. Oncology Letters, 2015, 10(5): 3035-3039.

[72] [72] HE J, YANG L P, YI W J,et al. Combination of fluorescence-guided surgery with photodynamic therapy for the treatment of cancer[J]. Molecular Imaging, 2017, 16: 1536012117722911.

[73] [73] SASAKI M, TANAKA M M U, ICHIKAWA H,et al.5-aminolaevulinic acid (5-ALA) accumulates in GIST-T1 cells and photodynamic diagnosis using 5-ALA identifies gastrointestinal stromal tumors (GISTs) in xenograft tumor models[J]. PLoS One, 2021, 16(4): e0249650.

[74] [74] PYE H, BUTT M A, FUNNELL L,et al. Using antibody directed phototherapy to target oesophageal adenocarcinoma with heterogeneous HER2 expression[J]. Oncotarget, 2018, 9(33): 22945-22959.

[75] [75] PARKIN D M, BRAY F, FERLAY J,et al. Global cancer statistics, 2002[J]. CA: A Cancer Journal for Clinicians, 2005, 55(2): 74-108.

[76] [76] RAOUL J L. Natural history of hepatocellular carcinoma and current treatment options[J]. Seminars in Nuclear Medicine, 2008, 38(2): S13-S18.

[77] [77] RUAN J, ZHENG H Y, RONG X D,et al. Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients[J]. Molecular Cancer, 2016, 15: 17.

[82] [82] CHEN Y, LIU W, SHANG Y,et al. Folic acid-nanoscale gadolinium-porphyrin metal-organic frameworks: fluorescence and magnetic resonance dual-modality imaging and photodynamic therapy in hepatocellular carcinoma[J]. International Journal of Nanomedicine, 2019, 14: 57-74.

[83] [83] YANG B, LIU H, YANG H,et al. Combinatorial photochemotherapy on liver cancer stem cells with organoplatinum (II) metallacage-based nanoparticles[J]. Journal of Materials Chemistry B, 2019, 7(42): 6476-6487.

[84] [84] HAMBLIN M R, VIVEIROS J, YANG C M,et al.Helicobacter pyloriaccumulates photoactive porphyrins and is killed by visible light[J]. Antimicrobial Agents and Chemotherapy, 2005, 49(7): 2822-2827.

[85] [85] BATTISTI A, MORICI P L, GHETTI F,et al. Spectroscopic characterization and fluorescence imaging ofHelicobacter pyloriendogenous porphyrins[J]. Biophysical Chemistry, 2017, 229: 19-24.

[87] [87] CHOI S S, LEE H K, CHAE H S.In vitrophotodynamic antimicrobial activity of methylene blue and endoscopic white light against Helicobacter pylori26695[J]. Journal of Photochemistry and Photobiology B: Biology, 2010, 101(3): 206-209.

[88] [88] FARAONI P L, GNERUCCI A, RANALDI F,et al. Side effects of intra-gastric photodynamic therapy: anin vitrostudy[J]. Journal of Photochemistry and Photobiology B: Biology, 2018, 186: 107-115.

[89] [89] IM B N, SHIN H, LIM B,et al. Helicobacter pylori-targeting multiligand photosensitizer for effective antibacterial endoscopic photodynamic therapy[J]. Biomaterials, 2021, 271: 120745.

[90] [90] QIAO Y Q, MA Y, TONG Y,et al. Phototherapy and mechanism exploration of biofilm and multidrug-resistantHelicobacter pyloriby bacteria-targeted NIR photosensitizer[J]. Small, 2023, 19(4): 2205248.

[91] [91] QIAO Y Q, HAN M F, FU H L,et al. Mucus-penetrating nanoassembly as potential oral phototherapeutic formulation against multi-drug resistant Helicobacter pyloriinfection[J]. Small, 2024, 20(20): e2306909.

[92] [92] KIM E J, CHOI J H, YANG H J,et al. Comparison of high and low molecular weight chitosan asin-vitroboosting agent for photodynamic therapy againstHelicobacter pyloriusing methylene blue and endoscopic light[J]. Photodiagnosis and Photodynamic Therapy, 2019, 26: 111-115.

[93] [93] WANG Y, GUO X H, ZHOU S N,et al. Selective photodynamic inactivation ofHelicobacter pyloriby a cationic benzylidene cyclopentanone photosensitizer: anin vitroandex vivostudy[J]. Journal of Photochemistry and Photobiology B: Biology, 2021, 223: 112287.

[94] [94] WILDER-SMITH C H, WILDER-SMITH P, GROSJEAN P,et al. Photoeradication ofHelicobacter pyloriusing 5-aminolevulinic acid: preliminary human studies[J]. Lasers in Surgery and Medicine, 2002, 31(1): 18-22.

[95] [95] GANZ R A, VIVEIROS J, AHMAD A,et al. Helicobacter pyloriin patients can be killed by visible light[J]. Lasers in Surgery and Medicine, 2005, 36(4): 260-265.

[96] [96] NG S C, SHI H Y, HAMIDI N M,et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies[J]. The Lancet, 2017, 390(10114): 2769-2778.

[97] [97] FAVRE L, BORLE F, VELIN D,et al. Low dose endoluminal photodynamic therapy improves murine T cell-mediated colitis[J]. Endoscopy, 2011, 43(7): 604-616.

[98] [98] REINHARD A, BRESSENOT A, DASSONNEVILLE R,et al. Photodynamic therapy relieves colitis and prevents colitis-associated carcinogenesis in mice[J]. Inflammatory Bowel Diseases, 2015, 21(5): 985-995.

[99] [99] MENG S, XU Z P, HONG G,et al. Synthesis, characterization andin vitrophotodynamic antimicrobial activity of basic amino acid-porphyrin conjugates[J]. European Journal of Medicinal Chemistry, 2015, 92: 35-48.

[101] [101] BORGLI H, THAMBAWITA V, SMEDSRUD P H,et al.HyperKvasir, a comprehensive multi-class image and video dataset for gastrointestinal endoscopy[J]. Scientific Data, 2020, 7(1): 283.

[102] [102] GABRECHT T, BORLE F, BERGH H,et al. Design of a light delivery system for the photodynamic treatment of the Crohn's disease[C]//Therapeutic Laser Applications and Laser-Tissue Interactions III. Munich, Germany, 2007: 66320Y.

[103] [103] RONG Y M, HONG G, ZHU N,et al.Photodynamic therapy of novel photosensitizer ameliorates TNBS-induced ulcerative colitis via inhibition of AOC1[J]. Frontiers in Pharmacology, 2021, 12: 746725.